Cargando…
Multi-omics reveal microbial determinants impacting the treatment outcome of antidepressants in major depressive disorder
BACKGROUND: There is a growing body of evidence suggesting that disturbance of the gut-brain axis may be one of the potential causes of major depressive disorder (MDD). However, the effects of antidepressants on the gut microbiota, and the role of gut microbiota in influencing antidepressant efficac...
Autores principales: | Wang, Yaping, Zhou, Jingjing, Ye, Junbin, Sun, Zuoli, He, Yi, Zhao, Yingxin, Ren, Siyu, Zhang, Guofu, Liu, Min, Zheng, Peng, Wang, Gang, Yang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464022/ https://www.ncbi.nlm.nih.gov/pubmed/37641148 http://dx.doi.org/10.1186/s40168-023-01635-6 |
Ejemplares similares
-
Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder
por: Sun, Zuoli, et al.
Publicado: (2023) -
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
por: Wang, Haixia, et al.
Publicado: (2022) -
Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder
por: Zhou, Jingjing, et al.
Publicado: (2021) -
Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder
por: Grant, Caroline W., et al.
Publicado: (2022) -
New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder
por: Katona, Cornelius L, et al.
Publicado: (2014)